Insider · CIK 0001897618

Karlin Daniel

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001897618

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−10.9K sh	$36.57	−$397K	792,846
2026-09-14	DFTXDefinium Therapeutics, Inc.A Award	Director, Chief Medical Officer	AAward	+200K sh	—	—	803,699
2026-08-12	DFTXDefinium Therapeutics, Inc.A Award	Director, Chief Medical Officer	AAward	+100K sh	—	—	603,282
2026-06-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−10K sh	$45.03	−$452K	503,282
2026-06-22	DFTXDefinium Therapeutics, Inc.A Award	Director, Chief Medical Officer	AAward	+100K sh	—	—	513,317
2026-03-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−8,018 sh	$18.47	−$148K	413,317
2026-02-03	DFTXDefinium Therapeutics, Inc.A Award	Director, Chief Medical Officer	AAward	+150K sh	—	—	575,025
2025-12-26	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−5,600 sh	$13.15	−$73.6K	425,025
2025-09-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−7,704 sh	$9.77	−$75.3K	430,625
2025-06-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−7,848 sh	$6.80	−$53.4K	438,329
2025-03-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−6,836 sh	$6.74	−$46.1K	446,177
2025-03-12	DFTXDefinium Therapeutics, Inc.A Award	Director, Chief Medical Officer	AAward	+115K sh	—	—	453,013
2024-12-26	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−6,643 sh	$7.43	−$49.4K	338,013
2024-09-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−6,871 sh	$5.98	−$41.1K	344,656
2024-06-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−6,925 sh	$7.22	−$50K	351,527
2024-03-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−6,578 sh	$9.50	−$62.5K	358,452
2024-02-27	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Medical Officer	AAward	+150K sh	—	—	150,000
2023-12-26	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−6,774 sh	$3.63	−$24.6K	365,030
2023-09-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−3,678 sh	$3.57	−$13.1K	375,044
2023-09-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−3,240 sh	$3.58	−$11.6K	371,804
2023-06-27	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−3,820 sh	$3.19	−$12.2K	381,685
2023-06-27	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−2,963 sh	$3.21	−$9,511.23	378,722
2023-03-14	DFTXDefinium Therapeutics, Inc.A Award	Director, Chief Medical Officer	AAward	+125K sh	—	—	385,505
2023-03-01	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−3,577 sh	$3.51	−$12.6K	260,505
2022-12-21	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−1,211 sh	$2.69	−$3,257.59	264,082
2022-10-27	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−644 sh	$3.00	−$1,932	265,293
2022-10-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−541 sh	$2.81	−$1,520.21	265,937
2022-09-27	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−640 sh	$5.87	−$3,756.8	266,478
2022-09-26	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−565 sh	$5.51	−$3,113.15	267,118
2022-08-31	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−1,204 sh	$11.67	−$14.1K	267,683
2022-07-27	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−9,856 sh	$0.69	−$6,800.64	4,033,264
2022-07-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−8,361 sh	$0.69	−$5,769.09	4,043,120
2022-06-27	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−26.2K sh	$0.70	−$18.4K	4,051,481
2022-05-27	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−9,555 sh	$0.82	−$7,835.1	4,077,719
2022-05-25	DFTXDefinium Therapeutics, Inc.S Sale	Director, Chief Medical Officer	SSale	−8,242 sh	$0.77	−$6,346.34	4,087,274
2022-04-26	DFTXDefinium Therapeutics, Inc.F Tax Payment	Director, Chief Medical Officer	FTax Payment	−13K sh	$0.81	−$10.6K	4,095,516
2022-03-28	DFTXDefinium Therapeutics, Inc.F Tax Payment	Director, Chief Medical Officer	FTax Payment	−10.2K sh	$1.17	−$11.9K	4,108,554
2022-03-24	DFTXDefinium Therapeutics, Inc.A Award	Director, Chief Medical Officer	AAward	+950K sh	—	—	4,118,757
2022-03-24	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Medical Officer	AAward	+1.25M sh	—	—	2,719,000
2022-02-26	DFTXDefinium Therapeutics, Inc.F Tax Payment	Director, Chief Medical Officer	FTax Payment	−118K sh	$1.21	−$143K	3,168,757

Recent filings

Accepted (ET)
Sep 294
Karlin Daniel0001104659-26-112065
SEC(opens sec.gov)
Sep 144
Karlin Daniel0001193125-26-389892
SEC(opens sec.gov)
Aug 124
Karlin Daniel0001193125-26-345838
SEC(opens sec.gov)
Jun 264
Karlin Daniel0001193125-26-285564
SEC(opens sec.gov)
Jun 224
Karlin Daniel0001193125-26-276878
SEC(opens sec.gov)
Mar 264
Karlin Daniel0001193125-26-126830
SEC(opens sec.gov)
Feb 54
Karlin Daniel0001193125-26-039576
SEC(opens sec.gov)
Dec 294
Karlin Daniel0001193125-25-335484
SEC(opens sec.gov)
Sep 264
Karlin Daniel0001193125-25-220843
SEC(opens sec.gov)
Jun 264
Karlin Daniel0000950170-25-090429
SEC(opens sec.gov)
Mar 264
Karlin Daniel0000950170-25-045396
SEC(opens sec.gov)
Mar 134
Karlin Daniel0000950170-25-038800
SEC(opens sec.gov)
Dec 274
Karlin Dan0001104659-24-132164
SEC(opens sec.gov)
Sep 254
Karlin Dan0000950170-24-109448
SEC(opens sec.gov)
Jun 254
Karlin Dan0000950170-24-077496
SEC(opens sec.gov)
Mar 264
Karlin Dan0000950170-24-036573
SEC(opens sec.gov)
Feb 294
Karlin Dan0000950170-24-023200
SEC(opens sec.gov)
Dec 264
Karlin Dan0000950170-23-073078
SEC(opens sec.gov)
Sep 254
Karlin Dan0000950170-23-049778
SEC(opens sec.gov)

Companies

Definium Therapeutics, Inc.Director, Chief Medical OfficerDFTX

Address

C/O DEFINIUM THERAPEUTICS, INC. ONE WORLD TRADE CENTER, SUITE 8500

NEW YORK, NY, 10007